Skip to main content

'Misjudgment' in employee matter leads to departure of East Bay drug maker CEO

The company isn't saying much about the specifics around Dan Browne's departure from the company he cofounded 20 years ago, but the company's stock is up under his replacement as president and CEO.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.